Last reviewed · How we verify
Empyema of pleura
Approved treatments
- Cleocin T · Pfizer
Cleocin T works by inhibiting protein synthesis in bacteria, preventing them from producing essential proteins and ultimately leading to cell death. - Cleocin · Generic (originally Upjohn/Pfizer)
Lincosamide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with excellent anaerobic coverage. - TICARCILLIN
- Ticarcillin
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Empyema of pleura patent landscape — cliff calendar, originator estates, attackable patents
- Empyema of pleura treatment landscape brief
- Empyema of pleura treatment updates RSS
Frequently asked questions about Empyema of pleura
What drugs treat Empyema of pleura?
Tracked treatments include Cleocin T, Cleocin, TICARCILLIN, Ticarcillin.
What is the treatment for Empyema of pleura?
Standard treatment for Empyema of pleura includes Cleocin T, Cleocin, TICARCILLIN, Ticarcillin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Empyema of pleura patent cliff · Empyema of pleura CI report
- Treatment: Cleocin T · Pfizer
- Treatment: Cleocin · Generic (originally Upjohn/Pfizer)
- Treatment: TICARCILLIN
- Treatment: Ticarcillin
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing